- BNF:
- 8.1.5
- Status:
- Do Not Prescribe (DNP)
- Decision Date:
- May 2016
Comments
DO NOT PRESCRIBE (DNP)6: NICE TA 389 - Topotecan is not recommended for treating recurrent platinum-resistant or platinum-refractory ovarian cancer. (Decision date - May 2016)
Do Not Prescribe (DNP) Drug Classifications
- 6: Have NICE guidance that recommends they should not be used
search again
